{"id":"W2525038995","doi":"10.1158/1078-0432.ccr-16-0987","title":"A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Discontinuation; Dutasteride; Abiraterone acetate; Urology; Prednisone; Internal medicine; Clinical endpoint; Oncology; Enzalutamide; Cancer; Androgen receptor; Androgen deprivation therapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002288246,0.000252758,0.0008672278,0.0002080995,0.000249226,0.00003728834,0.0002115879,0.00008671465,0.0004064935],"category_scores_gemma":[0.0002953586,0.000118504,0.0001376812,0.0005295001,0.001244573,0.0001676241,0.00009349587,0.000368156,0.000006768045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003390214,"about_ca_system_score_gemma":0.00326724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005560943,"about_ca_topic_score_gemma":0.0007959097,"domain_scores_codex":[0.9960403,0.0003425021,0.0008499817,0.0006838146,0.00124363,0.0008397266],"domain_scores_gemma":[0.9961961,0.001039708,0.0002302967,0.0005455258,0.0015172,0.0004711979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9151374,0.004520669,0.001908642,0.0005485825,0.001031969,0.0001229171,0.0002917078,0.000002537837,0.03151122,0.00008810742,0.00362099,0.04121522],"study_design_scores_gemma":[0.70835,0.2326648,0.001626512,0.001877848,0.0004630347,0.000007872798,0.0003622245,0.00009401741,0.0466511,0.0002726445,0.007308485,0.0003214211],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979015,0.0006573063,0.00008845425,0.01237231,0.00009597398,0.006709044,0.0006755294,0.00003156857,0.0003548438],"genre_scores_gemma":[0.9784477,0.001581639,0.0005507081,0.00006472428,0.0003151096,0.005294831,0.00005148039,0.00007163641,0.01362212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2281442,"threshold_uncertainty_score":0.5795944,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2647442452935844,"score_gpt":0.5426248698811699,"score_spread":0.2778806245875855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}